Literature DB >> 8929651

Big insulin-like growth factor II-producing hepatocellular carcinoma associated with hypoglycemia.

S Ishida1, M Noda, N Kuzuya, F Kubo, S Yamada, T Yamanaka, O Isozaki, N Hizuka, Y Kanazawa.   

Abstract

A 76-year-old female with a hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) was hospitalized because of fasting hypoglycemia. Her sera contained a low concentration of immunoreactive insulin and insulin-like growth factor (IGF)-I, while the IGF-II level was normal. However, most of the IGF-II consisted of the high molecular weight form (big IGF-II). The tumor tissue contained fetal type of IGF-II mRNA (6.0 kb). Furthermore, we found that one of the four patients examined with HCV-related HCC had big IGF-II in serum. This indicates that non-islet cell tumor hypoglycemia (NICTH) in HCV-related HCC might be accompanied by production of big IGF-II by the tumor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8929651     DOI: 10.2169/internalmedicine.34.1201

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  Recurrent hypoglycemic coma as the initial and single clinical manifestation of advanced hepatocellular carcinoma.

Authors:  Shutong Zhou; Lei Jiang; Mingxiao Sun
Journal:  J Gastrointest Cancer       Date:  2015-03

2.  Insulin-like growth factor-2 (IGF-2) activates estrogen receptor-α and -β via the IGF-1 and the insulin receptors in breast cancer cells.

Authors:  A E Richardson; N Hamilton; W Davis; C Brito; D De León
Journal:  Growth Factors       Date:  2011-03-16       Impact factor: 2.511

3.  Hypoglycemia, an atypical early sign of hepatocellular carcinoma.

Authors:  Marialuisa Sorlini; Federica Benini; Primarosa Cravarezza; Giuseppe Romanelli
Journal:  J Gastrointest Cancer       Date:  2010-09

Review 4.  Management of non-islet-cell tumor hypoglycemia: a clinical review.

Authors:  Timothy W Bodnar; Maria J Acevedo; Massimo Pietropaolo
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

5.  Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-II.

Authors:  Takuma Izutsu; Hiroyuki Ito; Izumi Fukuda; Hideki Tamura; Suzuko Matsumoto; Shinichi Antoku; Toshiko Mori; Hiroaki Goto
Journal:  Intern Med       Date:  2020-11-30       Impact factor: 1.271

6.  Non-islet cell tumor hypoglycemia as an initial presentation of hepatocellular carcinoma coupled with end-stage liver cirrhosis: A case report and review of literature.

Authors:  Bo Yu; Rana Douli; Jose Amaya Suarez; Victor Perez Gutierrez; Mohammad Aldiabat; Maria Khan
Journal:  World J Hepatol       Date:  2020-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.